Aprosulate sodium

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameAprosulate sodium
Drug Alias NameMW-2837MW 2837LW 10082LW-10082
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPlatelet aggregation inhibitors
TargetsNot applicable
Therapy Area/IndicationsThrombosisThromboembolism
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesDaiichi Sankyo Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDaiichi Sankyo Co Ltd
Active IndicationsN/A
Inactive IndicationsThrombosisThromboembolism

Other Information

ATC CodeN/A
Related LinksN/A